Keith Michael Gottesdiener's Net Worth

$38.2 Million

Estimate Recalculated Nov 11, 2024 08:40AM EST

Who is Keith Michael Gottesdiener?

Keith Michael Gottesdiener has an estimated net worth of $38.2 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., INTERCEPT PHARMACEUTICALS, INC., and Prime Medicine, Inc..

SEC CIK

Keith Michael Gottesdiener's CIK is 0001615856

Past Insider Trading and Trends

2018 was Keith Michael Gottesdiener's most active year for acquiring shares with 5 total transactions. Keith Michael Gottesdiener's most active month to acquire stocks was the month of April. 2019 was Keith Michael Gottesdiener's most active year for disposing of shares, totalling 14 transactions. Keith Michael Gottesdiener's most active month to dispose stocks was the month of October. 2020 saw Keith Michael Gottesdiener paying a total of $214,575.84 for 47,857 shares, this is the most they've acquired in one year. In 2018 Keith Michael Gottesdiener cashed out on 20,063 shares for a total of $513,210.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $49.25

CEO & President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.61%
3.41K
$6.14
$20,925.12
558.25K
Mar 9
Form 4
+1.25%
6.82K
$6.14
$41,850.24
554.28K
Feb 10
Form 4
+6.44%
33.07K
$4.59
$151,800.48
546.91K
Jan 8
Form 4
+1.48%
7.5K
$4.59
$34,425.00
513.84K
Jul 16
Form 4
-1.99%
-10.29K
$30.09
-$309,647.27
506.34K
Scheduled
Mar 15 - Mar 18
Form 4
-1.77%
-9.29K
$30.06
-$279,182.22
516.63K
Scheduled
Mar 13 - Mar 14
Form 4
-0.46%
-2.45K
$30.04
-$73,570.69
525.62K
Scheduled
Feb 26 - Feb 27
Form 4
-2.39%
-12.92K
$30.02
-$387,885.94
528.07K
Scheduled
Feb 15 - Feb 19
Form 4
-0.72%
-3.93K
$30.00
-$118,020.00
540.99K
Scheduled
Feb 13
Form 4
-2.81%
-15.78K
$30.05
-$474,175.75
544.92K
Scheduled
Jan 22 - Jan 23
Form 4
-1.77%
-10.12K
$30.01
-$303,551.15
560.7K
Scheduled
Jan 18
Form 4
-0.12%
-662.00
$30.00
-$19,860.00
570.81K
Scheduled
Jan 16
Form 4
-0.10%
-563.00
$30.00
-$16,890.00
571.48K
Scheduled
Dec 3
Form 4
-2.80%
-16.50K
$30.08
-$496,320.00
572.04K
Scheduled
Nov 2
Form 4
+0.51%
3K
$4.59
$13,770.00
588.54K
May 9
Form 4
—
0
—
—
0
Feb 14
Form 4
+4.88%
27.26K
—
—
585.54K
Oct 10
Form 3
—
0
—
—
0
No matching records found

INTERCEPT PHARMACEUTICALS, INC. (ICPT) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-32.83K
$19.00
-$623,770.00
0
Nov 8
Form 4
+32.81%
8.11K
—
—
32.83K
May 24
Form 4
+45.56%
7.74K
—
—
24.72K
May 25
Form 4
+70.62%
7.03K
—
—
16.98K
May 27
Form 4
+19.08%
1.59K
—
—
9.95K
May 28
Form 4
+23.13%
1.57K
—
—
8.36K
Jun 20
Form 4
+35.73%
1.79K
—
—
6.79K
Jun 20
Form 4
+30.57%
1.17K
$64.00
$74,944.00
5K
Apr 9
Form 4
+59.12%
1.42K
—
—
3.83K
Jun 27
Form 4
∞
2.41K
—
—
2.41K
Jul 19
Form 3
—
0
—
—
0
No matching records found

Prime Medicine, Inc. (PRME) Snapshot price: $3.4303

See Remarks

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
2.59M
Jun 5
Form 4
—
0
—
—
0
Feb 25
Form 4
-0.48%
-12.50K
—
—
2.59M
Nov 11
Form 4
—
0
—
—
0
Mar 31
Form 3
—
0
—
—
0
No matching records found